Author:
Romanos Marcel,Wewetzer Christoph,Schmeck Klaus
Reference56 articles.
1. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn (DSM-5TM). American Psychiatric Publishing, Washington/London
2. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (2011) AWMF S2-Leitlinie Psychiatrie: Persönlichkeitsstörungen. AWMF-Leitlinien-Register Nr. 038/015.
http://www.awmf.org/uploads/tx_szleitlinien/038-015m_01.pdf
. Accessed 6 June 2013
3. Bateman AW, Fonagy P (2000) Effectiveness of psychotherapeutic treatment of personality disorder. Br J Psychiatry 177:138–143
4. Becker DF, Grilo CM, Morey LC, Walker ML, Edell WS, McGlashan TH (1999) Applicability of personality disorder criteria to hospitalized adolescents: evaluation of internal consistency and criterion overlap. J Am Acad Child Psychiatry 38:200–205
5. Bellino S, Paradiso E, Bogetto F (2005) Oxcarbazepine in the treatment of borderline personality disorder: a pilot study. J Clin Psychiatry 66:1111–1115